Martin Göerner

ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited

Jörg D. Seebach, Georg Stüssi, Jakob Passweg et al. · Biology of Blood and Marrow Transplantation · 2005 · 136 citations · Full text

Medicine, Hematology, Immunology +14

Two years rituximab maintenance vs. observation after first-line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: First results of a prospective, randomized, multicenter phase II study (a subgroup study of the StiL NHL7-2008 MAINTAIN trial).

Mathias Rummel, Wolfgang Knauf, Martin Göerner et al. · Journal of Clinical Oncology · 2016 · 87 citations

Medicine, Hematology, Oncology +8

Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias

Martin Göerner, Theodore A. Gooley, Mary E.D. Flowers et al. · Biology of Blood and Marrow Transplantation · 2002 · 86 citations · Full text

Medicine, Hematology, Immunology +14

Sustained multilineage gene persistence and expression in dogs transplanted with CD34+ marrow cells transduced by RD114-pseudotype oncoretrovirus vectors

Martin Göerner, Peter A. Horn, Laura J. Peterson et al. · Blood · 2001 · 67 citations · Full text

Life Sciences, Molecular Biology, Gene Expression +14

Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE

Hartmut Goldschmidt, Marc‐Andrea Baertsch, Jana Schlenzka et al. · Leukemia · 2020 · 67 citations

Medicine, Oncology, Pharmacotherapy +15